Literature DB >> 1612782

Phosphorylation and estradiol binding of estrogen receptor in hormone-dependent and hormone-independent GR mouse mammary tumors.

A Migliaccio1, M Pagano, C C De Goeij, M Di Domenico, G Castoria, M Sluyser, F Auricchio.   

Abstract

The effect of phosphorylation on the hormone-binding capacity of the estrogen receptor (ER) was investigated in hormone-dependent (HD) and hormone-independent (HI) mammary carcinomas of GR mice. Tumor cytosols were incubated with ATP under conditions previously used to study the tyrosine kinase which confers hormone binding to phosphatase-treated or in vitro-synthesized ER. The ATP-dependent increases in hormone-binding capacity of 8 out of 20 HI tumors ranged from values of 23 to 124 fmol/mg cytosol protein. The enhancement by ATP of hormone binding to ER was significantly less marked in HD and HR tumors than in HI tumors. In only 3 out of 13 HD and HR tumors was an increase ranging from 15 to 20 fmol/mg protein detected. Analysis by Scatchard plot of estradiol binding to ER showed that cytosol incubation of HI tumors with ATP markedly increased the hormone binding without any change in affinity. The data suggest that ER of HI tumors is less phosphorylated in vivo than the ER of HD/HR tumors, so that the receptor of HI tumors is more susceptible to gamma-32P-ATP phosphorylation and ATP-induced hormone binding in vitro. Western blot of ER with antiphosphotyrosine antibody showed that, in HI tumors, the large ATP-induced increase in hormone binding to ER was associated with phosphorylation on tyrosine of the receptor itself. Our findings indicate that the process of activation-inactivation of binding through tyrosine-phosphorylation/phosphotyrosine-dephosphorylation of ER observed in estrogen target tissues is altered in some HI mammary tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1612782     DOI: 10.1002/ijc.2910510512

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  4 in total

Review 1.  Sex and the developing brain: suppression of neuronal estrogen sensitivity by developmental androgen exposure.

Authors:  N J MacLusky; D A Bowlby; T J Brown; R E Peterson; R B Hochberg
Journal:  Neurochem Res       Date:  1997-11       Impact factor: 3.996

2.  Tamoxifen aziridine labeling of the estrogen receptor-potential utility in detecting biologically aggressive breast tumors.

Authors:  S Trivedi; M Piccart; C Muquardt; N Gilot; S Hadiy; D Patel; G Leclercq
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  The Role of Curcumin in Prostate Cancer Cells and Derived Spheroids.

Authors:  Mariarosaria Boccellino; Pasqualina Ambrosio; Andrea Ballini; Danila De Vito; Salvatore Scacco; Stefania Cantore; Antonia Feola; Marzia Di Donato; Lucio Quagliuolo; Antonella Sciarra; Giovanni Galasso; Felice Crocetto; Ciro Imbimbo; Silvia Boffo; Erika Di Zazzo; Marina Di Domenico
Journal:  Cancers (Basel)       Date:  2022-07-09       Impact factor: 6.575

4.  Effects of coumestrol on estrogen receptor function and uterine growth in ovariectomized rats.

Authors:  B M Markaverich; B Webb; C L Densmore; R R Gregory
Journal:  Environ Health Perspect       Date:  1995-06       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.